Epivir Interactions
There are 54 drugs known to interact with Epivir (lamivudine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 15 are major, 38 are moderate, and 1 is minor.
- View all 54 medications that may interact with Epivir
- View Epivir alcohol/food interactions (1)
- View Epivir disease interactions (4)
Most frequently checked interactions
View interaction reports for Epivir (lamivudine) and the medicines listed below.
- acyclovir
- albuterol
- amlodipine
- AndroGel (testosterone)
- aspirin
- Ativan (lorazepam)
- atorvastatin
- clonazepam
- clonidine
- Crestor (rosuvastatin)
- gabapentin
- hydrochlorothiazide
- Intelence (etravirine)
- Isentress (raltegravir)
- Kaletra (lopinavir / ritonavir)
- levothyroxine
- Lipitor (atorvastatin)
- lisinopril
- Norvir (ritonavir)
- Plavix (clopidogrel)
- pravastatin
- Prezista (darunavir)
- ranitidine
- Reyataz (atazanavir)
- Sustiva (efavirenz)
- testosterone
- Tivicay (dolutegravir)
- trazodone
- Viread (tenofovir disoproxil)
- Ziagen (abacavir)
Epivir alcohol/food interactions
There is 1 alcohol/food interaction with Epivir (lamivudine).
Epivir disease interactions
There are 4 disease interactions with Epivir (lamivudine) which include:
Report options
QR code containing a link to this page
More about Epivir (lamivudine)
- Epivir consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
